Cabazitaxel in patients with metastatic castrate-resistant prostate cancer previously treated with a docetaxel-containing regimen: A single U.K. cancer center's experience using Early Access Programme and Cancer Drugs Fund.
Claire L. S. Kelly
No relevant relationships to disclose
Christina J. Hague
No relevant relationships to disclose
Stephanie A. Cornthwaite
No relevant relationships to disclose
Alison J. Birtle
No relevant relationships to disclose